Literature DB >> 26004530

Emerging role of neurotensin in regulation of the cardiovascular system.

Oleg E Osadchii1.   

Abstract

There is increasing evidence in support of an important role played by neurotensin (NT), a tridecapeptide originally found in bovine hypothalamus, in regulation of cardiovascular system. Elevated systemic levels of NT may contribute to pathogenesis of acute circulatory disoders, and predict the risk for cardiovascular morbidity and mortality in population-based studies. Within cardiovascular system, NT-containing neural fibers are found in close contact with atrial and ventricular cardiac myocytes, cardiac conduction system, intracardiac ganglia, as well as coronary vessels in humans and various animal species. The density of NT-immunoreactive innervation is reduced in cardiac disease. NT produces a variety of cardiovascular actions including effects on heart rate, myocardial contractility, systemic blood pressure, coronary vascular tone, venous smooth muscle tone, and regional blood flow in gastrointestinal tract, cutaneous and adipose tissue. NT could trigger cardiovascular reflexes by stimulating primary visceral afferents synaptically connected with preganglionic sympathetic neurons at the spinal cord. Structural determinants of biological activity of NT reside primarily in the C-terminal portion of its molecule which is responsible for receptor activation. NT effects are mediated via activation of NT receptors, or produced indirectly via stimulation of release of various endogenous neuromodulators/neurotransmitters such as histamine, catecholamines and prostaglandins. Three subtypes of NT receptor (NTS1, NTS2 and NTS3) have been shown to be expressed in the myocardium. NTS1, a high-affinity NT binding site coupled to phospholipase C-inositoltrisphosphate transduction pathway, is thought to mediate NT-induced cardiovascular responses.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular system; Neurotensin

Mesh:

Substances:

Year:  2015        PMID: 26004530     DOI: 10.1016/j.ejphar.2015.05.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  The role of neuropeptides in adverse myocardial remodeling and heart failure.

Authors:  Alexander Widiapradja; Prasad Chunduri; Scott P Levick
Journal:  Cell Mol Life Sci       Date:  2017-01-17       Impact factor: 9.261

2.  Pro-neurotensin/Neuromedin N and Hypertension Risk: A Prospective Study.

Authors:  Charles D Nicoli; D Leann Long; Timothy B Plante; George Howard; Suzanne E Judd; Janin Schulte; Mary Cushman
Journal:  Am J Hypertens       Date:  2022-03-08       Impact factor: 3.080

Review 3.  Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Vivek Narayan; Elizabeth W Thompson; Biniyam Demissei; Jennifer E Ho; James L Januzzi; Bonnie Ky
Journal:  J Am Coll Cardiol       Date:  2020-06-02       Impact factor: 24.094

4.  Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.

Authors:  James L Januzzi; Asya Lyass; Yuyin Liu; Hanna Gaggin; April Trebnick; Alan S Maisel; Ralph B D'Agostino; Thomas J Wang; Joseph Massaro; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-06-16       Impact factor: 8.311

Review 5.  Neuropeptide signalling systems - An underexplored target for venom drug discovery.

Authors:  Helen C Mendel; Quentin Kaas; Markus Muttenthaler
Journal:  Biochem Pharmacol       Date:  2020-06-30       Impact factor: 5.858

6.  Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism.

Authors:  Mattia Deluigi; Alexander Klipp; Christoph Klenk; Lisa Merklinger; Stefanie A Eberle; Lena Morstein; Philipp Heine; Peer R E Mittl; Patrick Ernst; Theodore M Kamenecka; Yuanjun He; Santiago Vacca; Pascal Egloff; Annemarie Honegger; Andreas Plückthun
Journal:  Sci Adv       Date:  2021-01-27       Impact factor: 14.136

7.  Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study).

Authors:  Nicholas Wettersten; Mary Cushman; Virginia J Howard; Oliver Hartmann; Gerasimos Filippatos; Neil Beri; Paul Clopton; George Howard; Monika M Safford; Suzanne E Judd; Andreas Bergmann; Joachim Struck; Alan S Maisel
Journal:  Am J Cardiol       Date:  2018-03-28       Impact factor: 2.778

8.  Neurotensin: a neuropeptide induced by hCG in the human and rat ovary during the periovulatory period†.

Authors:  Linah Al-Alem; Muraly Puttabyatappa; Ketan Shrestha; Yohan Choi; Kathy Rosewell; Mats Brännström; James Akin; Misung Jo; Diane M Duffy; Thomas E Curry
Journal:  Biol Reprod       Date:  2021-06-04       Impact factor: 4.285

Review 9.  Novel Agents and Future Perspectives on Theranostics.

Authors:  Lilja B Solnes; Monica Shokeen; Neeta Pandit-Taskar
Journal:  Semin Radiat Oncol       Date:  2021-01       Impact factor: 5.934

Review 10.  Neurohumoral Control of Sinoatrial Node Activity and Heart Rate: Insight From Experimental Models and Findings From Humans.

Authors:  Eilidh A MacDonald; Robert A Rose; T Alexander Quinn
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.